- Home
- Companies
- canada manitoba
- in vitro cell
Show results for
Refine by
In Vitro Cell Suppliers Serving Manitoba
39 companies found
based inHolliston, MASSACHUSETTS (USA)
BTX has been at the forefront of electroporation technology since we introduced the first commercially available electroporator in 1983. For over 30 years, we have made it our priority to focus only on electroporation and electrofusion. This focus ...
The Gemini Twin Wave Electroporators are flexible systems allowing both square wave and exponential decay wave electroporation in a single unit. Ideal for all of your electroporation needs, including CRISPR, in vivo, in vitro, in ...
based inAtlanta, GEORGIA (US) (USA)
AventaCell BioMedical Co., Ltd. ('AventaCell') is among the world leaders devoted to developing novel human-derived products for use in cell culture and tissue regeneration. Helios Bioscience is AventaCell's product family brand for their products ...
Mesenchymal stem cells (MSC) are multipotent cells with regenerative, multidifferentiation, and immunomodulatory capacities. Expanding MSC for clinical purposes usually requires large cell dose, which demanding efficient cultivation ...
based inFrederick, MARYLAND (USA)
RoosterBio, Inc. is radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) to propel the commercialization of regenerative technologies. RoosterBio is enabling living cellular technologies to become more affordable, ...
Human Mesenchymal Stem/Stromal Cells (hMSCs) are a heterogeneous cell population derived from a variety of tissue and donor sources. As a raw material in emerging cell, gene, and exosome based therapies, understanding the key quality attributes of ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
The inauguration of monoclonal antibodies (mAbs), derived from mice, were immunogenic in humans. These molecules were first synthesized in 1975 by Georges Köhler and César Milstein through the use of hybridoma technology. Later, in 1984, another ...
based inNeedham, MASSACHUSETTS (USA)
Invicro is an integral part of the REALM IDx, Inc. group, which aims to accelerate personalized medicine, discover novel therapeutic targets and develop innovative therapeutic technologies for unmet medical needs. As a global research partner to the ...
Radiopharmaceutical therapies represent an effective way to treat solid cancers by using tumor targeting small molecules, peptides or biologics to deliver a cytotoxic payload that induces DNA damage in tumor cells, while limiting damage to normal ...
based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
Bispecific T cell engaging receptors (TCER®) are off-the-shelf biologics that leverage the body’s immune system by redirecting and activating T cells towards cancer cells expressing specific tumor targets. The design of these novel ...
based inMontreal, QUEBEC (CANADA)
SCIREQ strives to make a strong impact on global pulmonary health by empowering scientists to better understand and eradicate lung diseases. The global burden of respiratory diseases is primarily driven by asthma, chronic obstructive pulmonary ...
based inDallas, TEXAS (USA)
Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past thirty years, Santa Cruz Biotechnology has focused on the ongoing development of research monoclonal antibodies, ...
Pheophorbide a is a chlorophyll-related compound studied for its anti-tumor and anti-cancer ...
based inCalgary, ALBERTA (CANADA)
Hemostemix (TSX V:HEM; OTCQB:HMTXF) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. Hemostemix’s proprietary platform technology is based on more ...
Hemostemix’s technology uses a patient’s own cells to treat that patient’s disease. The cornerstone of this autologous technology is a novel cell population within the blood called the synergetic cell population (SCP). The ...
based inKävlinge, SWEDEN
The Genovis Group consists of Genovis AB, Sweden, and the wholly owned subsidiary Genovis Inc., USA. The company's shares are listed on Nasdaq First North Growth Market. Genovis’ business concept is to offer customers in the biopharmaceutical and ...
GlyCLICK is a site-specific conjugation technology for IgG using Fc glycan remodeling and click-chemistry. The technology generates stable and homogenous antibody conjugates for IgG from several species and subclasses. Fc-glycan remodeling by ...
based inShirley, NEW YORK (USA)
As a scientists-founded and scientists-driven leading biotechnological company, Creative Biogene focuses on developing high quality products and services, as well as proprietary technology to support the research in the field of basic life sciences ...
Creative Biogene has developed the most experienced service of AAV, ranging from small crude scale to the large purified scale. We have the platform to offer the latest generation recombinant AAV stocks optimised for high levels of transgene ...
based inWellesley Hills, MASSACHUSETTS (USA)
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 50 countries, TargetMol has evolved into one of ...
based inDiepenbeek, BELGIUM
Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug ...
based inLaatzen, GERMANY
Rubarth Apparate GmbH produces since more than 65 years high-precision environmental simulation for science and industrial laboratories all over the world. Well-known companies, such as Novartis, BAYER, Nestle or Dr. Oetker, research institutions, ...
based inTallinn, ESTONIA
Gelatex Technologies is a materials technology company specialized in the high-throughput manufacturing of nanofibrous materials using proprietary halospinning technology - the world’s fastest and most cost-effective solution-spinning process. We ...
Gelacell™ is a non-woven highly porous scaffold specially designed for in vitro 3D cell culture and tissue engineering. It has a unique nanofibrous structure that closely mimics the natural extracellular matrix. ...
based inVaud, SWITZERLAND
Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufacturing of high-quality medical devices, intended for cells therapies. Regen Lab is a leading innovator of medical device in the field of ...
What is RegenKit Extracell BMC ? The Flexible & Reproducible Bone Marrow Concentrate System. Class IIb CE certified Medical ...
based inDidcot, UNITED KINGDOM
We design, develop and manufacture nanofibrous biomaterials for medical devices and regenerative medicine. Our technology platform is built on electrospinning and associated processing technologies. We are supporting clients with material ...
Significant advances in recent years mean that cell therapy is becoming a clinical reality. The unique characteristics of electrospun materials, including scaleability, minimal immunogenicity, regulatory familiarity and the ability to create a ...
based inShirley, NEW YORK (USA)
Creative Biostructure is specialized in providing cost-effective contract services to both academia and biotech/pharmaceutical industries in the field of structural biology and membrane protein technologies. We have developed an all-in-one, ...
based inAbingdon, UNITED KINGDOM
Founded on innovation and operating with an entrepreneurial flair, Oxford Optronix is a global pioneer in design, development and manufacture of sophisticated instrumentation for the life sciences. Our products are designed, developed and ...
based inPalo Alto, CALIFORNIA (USA)
Nirmidas Biotech was founded in September of 2013. We are a member of the Janssen Labs (JLABS) and QB3 programs, the Stanford StartX Med Program, and the MIT Industrial Liaison Program (MIT ILP). We are also a StartX Med COVID-19 Task Force Company ...